Status:
COMPLETED
Risk Stratified Multidisciplinary Ambulatory Management of Malignant Bowel Obstruction in Gynecological Cancers
Lead Sponsor:
University Health Network, Toronto
Conditions:
Gynecologic Cancer
Eligibility:
FEMALE
18-100 years
Brief Summary
Management of Malignant Bowel Obstruction (MBO) in Patients with Advanced Gynecological Cancers
Detailed Description
Guidelines for the management of patients with Malignant Bowel Obstruction(MBO) are not available and as such, there remains an urgent need for a collaborative approach to streamline patient care and ...
Eligibility Criteria
Inclusion
- Histologically and /or cytologically confirmed gynecological cancer, including ovarian, fallopian tube, endometrial, cervical or primary peritoneal cancer Deemed to be at risk of developing or have a clinical diagnosis of MBO as defined using the following criteria: clinical evidence of bowel obstruction (history/physical/radiological examination; and bowel obstruction beyond the ligament of Treitz.
Exclusion
- There are no specified exclusion criteria for this study
Key Trial Info
Start Date :
August 4 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT03260647
Start Date
August 4 2017
End Date
December 31 2024
Last Update
June 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Princess Margaret Cancer Centre
Toronto, Ontario, Canada